Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Stuttgart
08.01.26 | 13:17
4,235 Euro
+3,42 % +0,140
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
4,2004,24513:36

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiHalf Year Median Technologies Liquidity Contract Statement479Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were...
► Artikel lesen
MoMedian Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31, 2025158Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
08.12.25Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis LCS to Patients Across the U.S. and Europe275Non-exclusive commercial agreement for the distribution of eyonis LCS in the United States and Europe The agreement will become effective upon FDA 510(k) clearance Partner's robust...
► Artikel lesen
03.12.25Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025280Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
25.11.25Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting404Peer-reviewed scientific presentation: "Rethinking Lung Cancer Screening: Longitudinal AI/ML Diagnostics beyond Nodule Size Growth" AI Theater Presentation: "eyonis LCS: Transforming Lung...
► Artikel lesen
13.11.25Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2025277Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.11.25Lion Point Capital founder joins Median Technologies board3
03.11.25Median Technologies Appoints Didric Cederholm to Its Board of Directors287Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
28.10.25Median Technologies: €19 Million EIB Financing Raised To Boost AI-Enabled Cancer Diagnosis Platform2
23.10.25Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results420Operating loss reduced by €4 million in first six months of 2025 versus H1 2024, highlighting improved corporate efficiency H1 2025 revenues at €11.3 million, vs €10.9 million in H1 2024...
► Artikel lesen
21.10.25Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility332Proceeds to support the commercial launch of eyonis®LCS in the U.S. and Europe, and accelerate the broader development of eyonis®, Median's AI-powered Software as a Medical Device suite for early...
► Artikel lesen
13.10.25Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Ordinary and Extraordinary General Meeting on October 31, 2025263Regulatory News: The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Ordinary and Extraordinary...
► Artikel lesen
06.10.25Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2025266Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatoy News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
22.09.25Median Technologies Business Update Following Successful Financing304Cash runway extended until at least Q4 2026 and potentially well beyond eyonis® LCS commercial launch preparations underway in the U.S. eyonis® LCS subject to advanced negotiations...
► Artikel lesen
08.09.25Median Technologies: H2 2025 Financial Communication Calendar336Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company")manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
04.09.25Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025296Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
07.08.25Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2025332Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
01.08.25Median Technologies Has Completed a Capital Increase of € 23.9 Million589Capital increase of 23.9 million euros from institutional and retail investors at a subscription price of €1.66 per ABSA Extension of the Company's cash runway until Q4 2026 Regulatory...
► Artikel lesen
23.07.25Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies launches an approximately €22 million capital increase to support commercialization of eyonis LCS in the U.S. ...689Capital increase in the form of shares with attached warrants ("ABSA") without preferential subscription rights by way of an equity public offering and with a priority subscription period of 5...
► Artikel lesen
11.07.25Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB)603Regulatory News: Median Technologies FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1